Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
35 |
Global |
$3,500.00 |
|
Radiodermatitis - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$2,000.00 |
|
Diabetic Foot Ulcers - Pipeline Review, H2 2018 |
Nov 20 2018 |
138 |
Global |
$2,000.00 |
|
cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$3,500.00 |
|
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H2 2018 |
Nov 20 2018 |
79 |
Global |
$3,500.00 |
|
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
32 |
Global |
$3,500.00 |
|
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H2 2018 |
Nov 20 2018 |
86 |
Global |
$3,500.00 |
|
Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Pipeline Review, H2 2018 |
Nov 20 2018 |
35 |
Global |
$3,500.00 |
|
Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
40 |
Global |
$3,500.00 |
|
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline Review, H2 2018 |
Nov 20 2018 |
51 |
Global |
$3,500.00 |
|
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
39 |
Global |
$3,500.00 |
|
Fanconi Anemia - Pipeline Review, H2 2018 |
Nov 13 2018 |
53 |
Global |
$2,000.00 |
|
Peritonitis - Pipeline Review, H2 2018 |
Nov 13 2018 |
36 |
Global |
$2,000.00 |
|
RAC Beta Serine/Threonine Protein Kinase (Protein Kinase Akt 2 or Protein Kinase B Beta or RAC PK Beta or AKT2 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 13 2018 |
69 |
Global |
$3,500.00 |
|
Macular Edema - Pipeline Review, H2 2018 |
Nov 13 2018 |
50 |
Global |
$2,000.00 |
|
Irritable Bowel Syndrome - Pipeline Review, H2 2018 |
Nov 13 2018 |
132 |
Global |
$2,000.00 |
|
Hypoxia Inducible Factor 1 Alpha (ARNT Interacting Protein or Basic Helix Loop Helix PAS Protein MOP1 or Class E Basic Helix Loop Helix Protein 78 or Member Of PAS Protein 1 or PAS Domain Containing Protein 8 or HIF1A) - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$3,500.00 |
|
Aplastic Anemia - Pipeline Review, H2 2018 |
Nov 13 2018 |
80 |
Global |
$2,000.00 |
|
T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2018 |
Nov 13 2018 |
50 |
Global |
$3,500.00 |
|
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$3,500.00 |
|
Lung Transplant Rejection - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$2,000.00 |
|
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2018 |
Nov 13 2018 |
143 |
Global |
$3,500.00 |
|
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2018 |
Nov 13 2018 |
69 |
Global |
$3,500.00 |
|
Aspergillosis - Pipeline Review, H2 2018 |
Nov 13 2018 |
140 |
Global |
$2,000.00 |
|
Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2018 |
Nov 13 2018 |
140 |
Global |
$3,500.00 |
|
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2018 |
Nov 13 2018 |
74 |
Global |
$2,000.00 |
|
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018 |
Nov 13 2018 |
42 |
Global |
$2,000.00 |
|
Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H2 2018 |
Nov 13 2018 |
79 |
Global |
$3,500.00 |
|
Hypoparathyroidism - Pipeline Review, H2 2018 |
Nov 13 2018 |
51 |
Global |
$2,000.00 |
|
Benign Prostatic Hyperplasia - Pipeline Review, H2 2018 |
Nov 13 2018 |
114 |
Global |
$2,000.00 |
|